Treatment of tumors using specific anti-L1 antibody

The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.

Saved in:
Bibliographic Details
Main Authors MÖBIUS, ULRICH, LÜTTGAU, SANDRA, BREITLING, FRANK, BÄRREITER, SILKE, SEBENS, SUSANNE, KRÜGER, ACHIM, KELM, DANIELA, ALTEVOGT, PETER, MOLDENHAUER, GERHARD, LI, YI, SCHÄFER, HEINER
Format Patent
LanguageEnglish
Polish
Published 29.06.2018
Subjects
CHEMISTRY
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
Bibliography:Application Number: PL20130000027T